MannKind

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MannKind and other ETFs, options, and stocks.

About MNKD

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. 

CEO
Michael E. Castagna
CEOMichael E. Castagna
Employees
592
Employees592
Headquarters
Danbury, Connecticut
HeadquartersDanbury, Connecticut
Founded
1991
Founded1991
Employees
592
Employees592

MNKD Key Statistics

Market cap
819.55M
Market cap819.55M
Price-Earnings ratio
139.57
Price-Earnings ratio139.57
Dividend yield
Dividend yield
Average volume
12.12M
Average volume12.12M
High today
$2.83
High today$2.83
Low today
$2.52
Low today$2.52
Open price
$2.62
Open price$2.62
Volume
4.84M
Volume4.84M
52 Week high
$6.51
52 Week high$6.51
52 Week low
$2.52
52 Week low$2.52

Stock Snapshot

MannKind(MNKD) stock is priced at $2.66, giving the company a market capitalization of 819.55M. It carries a P/E multiple of 139.57.

On 2026-03-09, MannKind(MNKD) stock moved within a range of $2.52 to $2.83. With shares now at $2.66, the stock is trading +5.5% above its intraday low and -6.0% below the session's peak.

Trading activity shows a volume of 4.84M, compared to an average daily volume of 12.12M.

The stock's 52-week range extends from a low of $2.52 to a high of $6.51.

The stock's 52-week range extends from a low of $2.52 to a high of $6.51.

MNKD News

TipRanks 4d
MannKind price target lowered to $8 from $10 at Wedbush

Wedbush lowered the firm’s price target on MannKind (MNKD) to $8 from $10 and keeps an Outperform rating on the shares. Last week’s Q4 update, despite strong re...

Analyst ratings

89%

of 9 ratings
Buy
88.9%
Hold
11.1%
Sell
0%

People also own

Based on the portfolios of people who own MNKD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.